These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 29914296)
1. Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine. Elbadawi A; Barssoum K; Abuzaid AS; Rezq A; Biniwale N; Alotaki E; Mohamed AH; Vuyyala S; Ogunbayo GO; Saad M Acta Cardiol; 2019 Apr; 74(2):124-129. PubMed ID: 29914296 [TBL] [Abstract][Full Text] [Related]
2. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature. Manolis AS Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial. Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325 [TBL] [Abstract][Full Text] [Related]
4. Patent Foramen Ovale Closure for Treating Migraine: A Meta-Analysis. Zhang Y; Wang H; Liu L J Interv Cardiol; 2022; 2022():6456272. PubMed ID: 35185398 [TBL] [Abstract][Full Text] [Related]
5. Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine. Mojadidi MK; Kumar P; Mahmoud AN; Elgendy IY; Shapiro H; West B; Charles AC; Mattle HP; Sorensen S; Meier B; Silberstein SD; Tobis JM J Am Coll Cardiol; 2021 Feb; 77(6):667-676. PubMed ID: 33573735 [TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Percutaneous Patent Foramen Ovale Closure on Migraine: a Meta-Analysis of Randomized Controlled Trials and Observational Studies. Zhang QQ; Lu JJ; Yan MY; Hu XW; Qin YR; Wang DP; Jiang JH; Fang Q; Zhao HR Biomed Res Int; 2021; 2021():6643266. PubMed ID: 33748272 [TBL] [Abstract][Full Text] [Related]
7. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Mattle HP; Evers S; Hildick-Smith D; Becker WJ; Baumgartner H; Chataway J; Gawel M; Göbel H; Heinze A; Horlick E; Malik I; Ray S; Zermansky A; Findling O; Windecker S; Meier B Eur Heart J; 2016 Jul; 37(26):2029-36. PubMed ID: 26908949 [TBL] [Abstract][Full Text] [Related]
10. PFO and Migraine: Is There a Role for Closure? Rayhill M; Burch R Curr Neurol Neurosci Rep; 2017 Mar; 17(3):20. PubMed ID: 28283958 [TBL] [Abstract][Full Text] [Related]
12. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt. Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153 [TBL] [Abstract][Full Text] [Related]
13. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132 [TBL] [Abstract][Full Text] [Related]
15. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale. Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study. Qi Y; Zhang Y; Luo X; Cheng G; Du Y; Liu R; Xie H; Cheng Y; Guo Y; Luo G J Investig Med; 2021 Jan; 69(1):7-12. PubMed ID: 32928904 [TBL] [Abstract][Full Text] [Related]
17. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study. Chessa M; Colombo C; Butera G; Negura D; Piazza L; Varotto L; Bussadori C; Fesslova V; Meola G; Carminati M J Cardiovasc Med (Hagerstown); 2009 May; 10(5):401-5. PubMed ID: 19449455 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Kwong JS; Lam YY; Yu CM Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879 [TBL] [Abstract][Full Text] [Related]
19. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials. Wang TKM; Wang MTM; Ruygrok P Heart Lung Circ; 2019 Apr; 28(4):623-631. PubMed ID: 29602754 [TBL] [Abstract][Full Text] [Related]
20. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials. Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]